$BLMH.c is going to smash 2022. After surpassing Q2 financial expectations, reporting $11.1 million in revenue, Bloom Health Partners (CSE: BLMH) is on track to smash its yearly guidance.
In this recent interview, CEO Andre Morton stated the company is executing the plan it has promised investors. $BLMH.c has provided guidance of $25-$28 million in revenue for this year, which would take its SP to well over $1 based on its P/E ratio at the beginning of this year.
Really excited to watch this company’s performance over the coming months. I’m expecting some highly impressive things.
$BLMH.c is currently trading at $.205, valued at $8 million.
https://investingnews.com/bloom-health-partners-ceo-andrew-morton/